Answer
Dabrafenib mesilate inhibits tumour phosphorylated ERK relative to baseline in subjects with BRAF V600 mutation-positive melanoma.
Sources for this answer
- Tafinlar 50 mg & 75 mg hard capsulesNovartis Pharmaceuticals UK Ltd · emc · SmPC §5.1 Pharmacodynamic properties · Version 40Document updated
Sources checked